APA (7th ed.) Citation

Ramirez, C., Kee, C., Sharma, A. K., Thomas, L., Schmidt, F. I., Stanifer, M., . . . Herrmann, C. (2021). The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity. PLoS pathogens, 17(6), . https://doi.org/10.1371/journal.ppat.1009687

Chicago Style (17th ed.) Citation

Ramirez, Carlos, Carmon Kee, Ashwini Kumar Sharma, Leonie Thomas, Florian I. Schmidt, Megan Stanifer, Steeve Boulant, and Carl Herrmann. "The Endogenous Cellular Protease Inhibitor SPINT2 Controls SARS-CoV-2 Viral Infection and Is Associated to Disease Severity." PLoS Pathogens 17, no. 6 (2021). https://doi.org/10.1371/journal.ppat.1009687.

MLA (9th ed.) Citation

Ramirez, Carlos, et al. "The Endogenous Cellular Protease Inhibitor SPINT2 Controls SARS-CoV-2 Viral Infection and Is Associated to Disease Severity." PLoS Pathogens, vol. 17, no. 6, 2021, https://doi.org/10.1371/journal.ppat.1009687.